COVID-19 disease with positive fecal and negative pharyngeal and sputum viral tests

American Journal of Gastroenterology

Volumn 115, Issue 5, 2020, Pages 790-

  Chen, Lijuan ^a   Lou, Jianghua ^a   Bai, Yan ^a   Wang, Meiyun ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT;

ADULT; CASE REPORT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORONAVIRUS DISEASE 2019; ERYTHROCYTE SEDIMENTATION RATE; FECES ANALYSIS; FEMALE; FEVER; HOSPITAL CARE; HUMAN; LETTER; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; OUTPATIENT CARE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPUTUM ANALYSIS; SYMPTOM; THROAT CULTURE; TRAVEL;

EID: 85083106419     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.14309/ajg.0000000000000610     Document Type: Letter

References (4)

1. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med [Epub ahead of print February 18, 2020.]
2. Guan W, Ni Z, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med [Epub ahead of print February 28, 2020.]
3. Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. Lancet 2003; 361(9371):1767-72.
4. Goh GK, Dunker AK, Uversky V. Prediction of intrinsic disorder in MERS-CoV/HCoVEMC supports a high oral-fecal transmission. PLoS Curr 2013;5.